Hon S Leong is a translational urology researcher based at
Sunnybrook Hospital. He received his Bachelor of Science at the University of
Alberta (1999) and his Master of Science at the University of British Columbia
(2003). He then received his Doctor of Philosophy at the University of British
Columbia (2008). He was also an Honorary Fellow at the National Heart and Lung
Institute of the Royal Brompton and Harefield Hospitals in London, UK for two
years. During his Ph.D. training, he was awarded several prestigious awards
such as a CIHR studentship in transplantation, a Canadian Blood Services
studentship in blood transfusion medicine, the Michael Smith Foundation of
Health Research Ph.D. award, and the British Heart Foundation Bursary award. After
completing his Ph.D., he shifted to cancer research. He was awarded various
fellowship awards (CIHR, CBCF), culminating in being the first Canadian
recipient of a U.S. Army Department of Defense Prostate Cancer Research Program
Fellowship. He has received many awards and honors, including the Movember
Rising Star Award in 2013 and again in 2016. He was named Department of Surgery
Outstanding Scientist in 2015 at the University of Western Ontario as an
Assistant Professor (2014–2016). He was also awarded the New Investigator Award
in 2016 by the Kidney Foundation of Canada for his work on kidney stone drug
treatments. At Mayo Clinic, he was Director of the Urologic Sciences laboratory
(2016–2019).
Hon S Leong is a translational urology researcher based at
Sunnybrook Hospital. He received his Bachelor of Science at the University of
Alberta (1999) and his Master of Science at the University of British Columbia
(2003). He then received his Doctor of Philosophy at the University of British
Columbia (2008). He was also an Honorary Fellow at the National Heart and Lung
Institute of the Royal Brompton and Harefield Hospitals in London, UK for two
years. During his Ph.D. training, he was awarded several prestigious awards
such as a CIHR studentship in transplantation, a Canadian Blood Services
studentship in blood transfusion medicine, the Michael Smith Foundation of
Health Research Ph.D. award, and the British Heart Foundation Bursary award. After
completing his Ph.D., he shifted to cancer research. He was awarded various
fellowship awards (CIHR, CBCF), culminating in being the first Canadian
recipient of a U.S. Army Department of Defense Prostate Cancer Research Program
Fellowship. He has received many awards and honors, including the Movember
Rising Star Award in 2013 and again in 2016. He was named Department of Surgery
Outstanding Scientist in 2015 at the University of Western Ontario as an
Assistant Professor (2014–2016). He was also awarded the New Investigator Award
in 2016 by the Kidney Foundation of Canada for his work on kidney stone drug
treatments. At Mayo Clinic, he was Director of the Urologic Sciences laboratory
(2016–2019).